Related references
Note: Only part of the references are listed.Multivalent Design of Apoptosis-Inducing Bid-BH3 Peptide-Oligosaccharides Boosts the Intracellular Activity at Identical Overall Peptide Concentrations
Martin Richter et al.
CHEMISTRY-A EUROPEAN JOURNAL (2012)
Chemoselective Staudinger-phosphite reaction of symmetrical glycosyl-phosphites with azido-peptides and polygycerols
Verena Boehrsch et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2012)
Epidermal Growth Factor-PEG Functionalized PAMAM-Pentaethylenehexamine Dendron for Targeted Gene Delivery Produced by Click Chemistry
Haijun Yu et al.
BIOMACROMOLECULES (2011)
Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives
Yiyun Cheng et al.
CHEMICAL SOCIETY REVIEWS (2011)
Long-Acting Lipidated Analogue of Human Pancreatic Polypeptide Is Slowly Released into Circulation
Kathrin Bellmann-Sickert et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Coupling to Polymeric Scaffolds Stabilizes Biofunctional Peptides for Intracellular Applications
Ivo R. Ruttekolk et al.
MOLECULAR PHARMACOLOGY (2011)
Aza-dibenzocyclooctynes for fast and efficient enzyme PEGylation via copper-free (3+2) cycloaddition
Marjoke F. Debets et al.
CHEMICAL COMMUNICATIONS (2010)
Phosphoramidate-peptide synthesis by solution- and solid-phase Staudinger-phosphite reactions
Remigiusz A. Serwa et al.
JOURNAL OF PEPTIDE SCIENCE (2010)
Multifunctional Tumor-Targeted Polymer-Peptide-Drug Delivery System for Treatment of Primary and Metastatic Cancers
Pooja Chandna et al.
PHARMACEUTICAL RESEARCH (2010)
Site-specific PEGylation of proteins by a Staudinger-phosphite reaction
Remigiusz Serwa et al.
CHEMICAL SCIENCE (2010)
Development of HPMA copolymer-anticancer conjugates: Clinical experience and lessons learnt
Ruth Duncan
ADVANCED DRUG DELIVERY REVIEWS (2009)
Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers
Younsoo Bae et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Chemoselective Staudinger-Phosphite Reaction of Azides for the Phosphorylation of Proteins
Remigiusz Serwa et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Clickable'' elastins: elastin-like polypeptides functionalized with azide or alkyne groups
Rosalie L. M. Teeuwen et al.
CHEMICAL COMMUNICATIONS (2009)
Enzymatic N-terminal addition of noncanonical amino acids to peptides and proteins
Rebecca E. Connor et al.
CHEMBIOCHEM (2008)
Size comparison between proteins PEGylated with branched and linear Poly(Ethylene glycol) molecules
Conan J. Fee
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Targeted proapoptotic anticancer drug delivery system
Pooja Chandna et al.
MOLECULAR PHARMACEUTICS (2007)
C-terminally PEGylated hGH-derivatives
Bernd Peschke et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Pharmacokinetic consequences of pegylation
Mehrdad Hamidi et al.
DRUG DELIVERY (2006)
Strategies to improve plasma half life time of peptide and protein drugs
M. Werle et al.
AMINO ACIDS (2006)
PEGylation, successful approach to drug delivery
FM Veronese et al.
DRUG DISCOVERY TODAY (2005)
Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix
LD Walensky et al.
SCIENCE (2004)
C-terminal site-specific PEGylation of a truncated thrombomodulin mutant with retention of full bioactivity
CS Cazalis et al.
BIOCONJUGATE CHEMISTRY (2004)
Site-specific PEGylation of proteins containing unnatural amino acids
A Deiters et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Caspase-3 activation is an early event and initiates apoptotic damage in a human leukemia cell line
J Varghese et al.
APOPTOSIS (2003)
Extending the applicability of carboxyfluorescein in solid-phase synthesis
R Fischer et al.
BIOCONJUGATE CHEMISTRY (2003)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics
A Letai et al.
CANCER CELL (2002)
Peptide and protein PEGylation: a review of problems and solutions
FM Veronese
BIOMATERIALS (2001)
Rational design of a potent, long-lasting form of interferon:: A 40 kDa branched polyethylene glycol-conjugated interferon α-2a for the treatment of hepatitis C
P Bailon et al.
BIOCONJUGATE CHEMISTRY (2001)
Share Paper
